Pituitary Adenoma

Common data elements are needed to reduce heterogeneity in studies on transsphenoidal pituitary adenoma surgery, according to a systematic review published in Pituitary.

Most adults with incident pituitary microadenomas have no change in size or a decrease in size during a median follow-up of nearly 5 years, according to findings published in Annals of Internal Medicine.

Adults with a high BMI have an increased risk for pituitary adenoma, with the risk even greater for those with a high BMI during early adulthood, according to findings published in the Journal of Clinical Endocrinology & Metabolism.

Nearly 20% of pediatric brain tumors occur in the pituitary region, and more than two-thirds of pituitary region tumors were present in girls, according to study findings published in Pituitary.

Surgeons’ preference for an endoscope over the microscope for transsphenoidal surgery visualization during pituitary surgery more than doubled during the past 10 years, according to survey data.

Treatment with recombinant human growth hormone does not increase the risk for nonfunctioning pituitary adenoma or craniopharyngioma among adults with GH deficiency, according to an analysis of retrospective data published in The Journal of Clinical Endocrinology & Metabolism.

Endocrine Today has compiled a list of the top recent news reports focused on neuroendocrinology and adrenal medicine.

Obesity is common at diagnosis of pituitary adenoma in childhood and may persist despite successful treatment, according to findings published in Clinical Endocrinology.

For patients with persistent or recurring Cushing’s disease, monthly pasireotide therapy was safe and effective, leading to normal urinary free cortisol levels in 47% of patients after 2 years, according to findings published in Clinical Endocrinology.